# Dynamic alterations of circulating lymphocytes during the trajectory of Hantaan virus-induced hemorrhagic fever with renal syndrome

## TL;DR

This study tracks changes in immune cells during Hantaan virus-induced kidney disease, revealing patterns linked to disease severity and recovery.

## Contribution

The study provides the first comprehensive longitudinal analysis of circulating lymphocyte dynamics in HTNV-induced HFRS.

## Key findings

- CD8+ T cells and related subsets peak during febrile/oliguric phases, then decline in recovery.
- Higher CD8+ Tem, B, and CD56dim NK cells in the febrile phase correlate with severe disease.
- CD4+ Tcm levels in the oliguric phase mark progression to severe HFRS.

## Abstract

Hemorrhagic fever with renal syndrome (HFRS) is a zoonotic disease with high mortality. Almost 90% of global cases of HFRS are induced by Hantaan virus (HTNV) infection. Although lymphocyte dysfunction is a critical factor in HFRS progression, the specific immune dynamics of HTNV remain unexplored, and current analyses predominantly depend on single-time point sampling. Therefore, comprehensive longitudinal studies are needed to characterize circulating lymphocyte dynamics during HTNV-induced HFRS progression.

In this study, we conducted a flow cytometric analysis of circulating lymphocytes in 39 patients with HTNV-induced HFRS across different clinical phases. The analysis encompassed conventional T cells, unconventional T cells, B cells, NK cells and their respective repertoires.

Here, we revealed phase-specific immune patterns: CD8+ T, CD8+ Tems, and activated CD8+ T, MAIT and NKT cells peaked during febrile/oliguric phases before declining in polyuria/recovery, while CD4+ T and MAIT cells showed inverse fluctuation patterns. Higher frequencies of CD8+ Tem, B, and CD56dim NK cells during the febrile phase correlated with severe disease, enabling early risk stratification. Lower CD4+ Tcm levels in the oliguric phase marked progression to severe HFRS, indicating potential therapeutic strategies aimed at enhancing CD4+ Tcm generation or inhibiting effector differentiation. Additionally, CD38 and CD161 expression predicted specific lymphocyte subset dynamics, offering novel biomarkers for immunomodulatory strategies. Our study thus provides the first comprehensive atlas of lymphocyte evolution in HTNV-induced HFRS, connecting immune dysregulation with clinical outcomes.